Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biomarin Pharmaceutical (BMRN) Q2 2018 Earnings
BMRN
25
Apr
Confirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-0.4
-0.29
-0.18
-0.07
Details
Expected EPS
-0.18
Actual EPS
-0.25
Surprise EPS
-0.07
Surprise Percent
+38.89%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of -0.25 per share for Q2 2018.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login